Please login to the form below

Not currently logged in
Email:
Password:

Ian Weatherhead joins Ipsen

Takes up corporate communications role at the French pharma firm

Ipsen Dr Ian WeatherheadFrench biopharmaceutical company Ipsen has appointed Ian Weatherhead as vice president, corporate external communications.

He brings 20 years of corporate communications experience within the life sciences sector, most recently at Teva UK/Ireland where he led its corporate communications and government affairs team.

Prior to that he held global, regional and affiliate roles with AstraZeneca, Syngenta, UCB and Sanofi.

In his new role at Ipsen Weatherhead will be responsible for the design and implementation of an external corporate communications strategy.

Reporting to senior vice president, public affairs and

corporate communications Didier Veron, Weatherhead will also oversee Ipsen’s media and public relations, digital communications, and corporate image and reputation.

Veron said: “I am delighted that Ian is joining the team to advance our external communications strategy as Ipsen continues its evolution into a leading global biopharmaceutical company focused on innovation and specialty care. He brings a wealth of experience in the pharmaceutical sector.”

13th September 2017

From: Marketing

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

Flu
Influenza – the risk to vulnerable populations
Why we can't get complacent about flu vaccination...
dementia
Alzheimer’s Research UK highlights socio-economic inequalities in dementia risk
The charity aims to improve the number of women participating in dementia research and grow awareness of dementia risk factors...
Data security
Concerns about data security are building a strong case for clinical mobility in EMEA
Electronic medical records have transformed the storage of sensitive information but how can the healthcare sector continue to protect patient and staff data?...